DCF — AULTMAN ORRVILLE HOSPITAL
Enterprise Value: $8.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$8.4M
Enterprise Value
$1.0M
PV of Cash Flows
$7.4M
PV of Terminal Value
$11.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $59.8M | $2.3M | 4.0% | $-0.5M | $-0.4M |
| Year 2 | $61.6M | $3.0M | 5.0% | $-0.0M | $-0.0M |
| Year 3 | $63.5M | $3.7M | 6.0% | $0.5M | $0.3M |
| Year 4 | $65.4M | $4.1M | 6.0% | $0.7M | $0.5M |
| Year 5 | $67.4M | $4.4M | 7.0% | $0.9M | $0.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $8.4M. Terminal value accounts for 89% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$58.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.032859033440378195
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5